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ABSTRACT 
 
Objectives: This study was carried out to determine the metabolic syndrome risk and related factors of metabolic 
syndrome risk. Material and Methods: This descriptive study was conducted on three outpatient clinics of 
Cardiology at Adıyaman University Training and Research Hospital. The sample of the study consisted 268 patients 
who agreed to participate the study. Data was collected by questionnaire. The Statistical Package for the Social 
Sciences (SPSS, version 16.0 for Windows) were used the analyze data. Percentage and Chi-Square test were used 
to evaluate for data. Results: The 58.6% of patients were female, 86.6% of them were married. The 67.5% of 
patients had chronic disease and 32.1% of these patients first degree relatives had chronic disease. The 44.8% of 
patients were overweight and 26.9% of patients were obesite. 42.5% of the patients had the high risk, 48.5% of the 
patients had medium risk of metabolic syndrome. There was statistically significant relationship between metabolic 
syndrome risk and age, gender, marital status, having chronic diseases (p<0.05). There was statistically significant 
relationship between metabolic syndrome risk body mass index and hypertension (p<0.05). Conclusion:  The 
majority of patients who were admitted to the Cardiology outpatient clinics had medium and high MS risk. There 
was statistically significant relationship between MS risk and age, gender, marital status, education level, body mass 
indeks, chronic disease. 
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Introduction 
Metabolic syndrome (MS) is the occurrence of 
cardiovascular risk factors like hypertension, 
dyslipidemia (especially high triglyceride, low high-
density lipoprotein (HDL), low-density lipoprotein 
(LDL) increase), obesity (especially central or 
abdominal obesity), insulin resistance, glucose 
intolerance or Diabetes Mellitus [1]. MS is known 
since 1923 and has been called by various names. 
However, in 1998, World Health Organization (WHO) 
has suggested in a report issued to call it as MS [2].  
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Many organizations have developed diagnostic criteria 
for MS. But because of its ease of application, the 
diagnostic criteria defined by National Cholesterol 
Education Program Adult Treatment Panel III (NCEP 
ATP III) is the most widely accepted definition in 
practical life [3]. ATP III took as base the presence of 
at least three of the criteria as abdominal obesity, high 
blood pressure, hypertriglyceridemia, low HDL 
cholesterol and fasting hyperglycemia. ATP III 
proposed the limit values of waist circumference for 
male <102 cm and female <88 cm by emphasizing that 
abdominal obesity is an important element in the 
development of the syndrome. However, it was 
emphasized that these values of waist circumference 
derived from obese American society may be incorrect 
for adapting to different societies and even there are 
societies below these values as the MS can develop 
within. In addition, ATP III has stated that MS 
diagnosis can be made in existence of type 2 diabetes 
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mellitus [4]. As a result of rapid epidemiological and 
socio-economic transformation in Turkey, the changes 
in lifestyle and negative increase in MS risk factors 
lead to high prevalence of MS. According to the study 
conducted by Turkey Metabolic Syndrome Research 
Group (METSAR), in our country’s urban areas MS 
prevalence is 33.9% [5]. In our country, as in many 
developed countries, coronary artery disease and 
cerebrovascular events are leading causes of death in 
adults. In a study conducted by World Health 
Organization (WHO), it was found that MS increase 
the risk of coronary artery disease and stroke 4 times 
more [6]. Nevertheless, the MS is the overall risk factor 
which can be controlled. Primary prevention in the 
fight against chronic diseases, includes recognition and 
practices related to the elimination of the risk factors of 
the disease. With the primary prevention which 
requires the important responsibility of nurses; the 
development of the individual and public health is 
possible with the significant prevention of the early 
death caused by vascular diseases and diabetes. 
Therefore, the identification of individuals at risk for 
MS, support of their healthy lifestyle behaviors 
(healthy diet, excercise and smoking cessation) are 
important contributions to public health [7].For 
diagnosis of MS, anthropometric measurements, blood 
pressure and some laboratory findings of patients 
should be evaluated together. Especially in rural areas 
where laboratory studies can not be done, to determine 
the individuals with medium and high-risk for MS with 
non-invasive techniques and to direct those people to 
health care services, can contribute early diagnosis and 
treatment of MS and thus can contribute to the 
prevention of the development of many diseases 
associated with MS. Therefore in this study, by using 
MS risk research form, it was aimed to determine the 
risk of MS of patients who admitted to the cardiology 
clinic and the factors associated with MS risk. 
 
Materials and Methods 
 
The purpose of this cross-sectional and descriptive 
study was to determine the MS risk and the factors that 
were related to MS risk of the patients who have 
admitted to the outpatient clinic of cardiology. 
Population-Sample  
The population of the research comprised the patients 
who had admitted to the cardiology outpatient clinic of 
the Adıyaman University Training and Research 
Hospital which is located to city center of Adıyaman, 
in 15th September-15th October 2013. The sample of 
the study comprised the 268 patients who have 
accepted to participate to the research.  
Data Collection Tools 
Research data was collected by employing the 
questionnaire form developed by the researchers and 
metabolic syndrome research form including 14 items 
which is developed by Erdoğmuş. 
Questionnaire Form  
Questionnaire form comprised 16 items related to 
patients’ sociodemographic characteristics and medical 
history and record sheet of blood pressure, pulse, 
height, and weight and waist circumference 
Metabolic Syndrome Research Form 
It includes 14 items developed by specialist doctor 
Onur Erdoğmuş. The questionnaire items are answered 
as “Yes” or “No”. This form is evaluated as low risk 
for MS at 0-4 scores, medium risk for MS at 5-8 score 
(it is suggested to be investigated) and high risk for MS 
at 9-14 scores (it is suggested to be investigated) [8].  
Anthropometric Measures  
The height of the patients was measured by the 
researcher by taking of the shoes of them to minimize 
the error rate. The weight of the patients was measured 
by standard bascule by taking of the additional clothes 
of the patients. After these measurement patients body 
mass index (BMI) was computed with the following 
formula, BMI=Wight (kg)/Height (m2). The patients 
are evaluated according to their BMI scores: BMI score 
below 18.50 as thin, BMI score between 18.50 and 
24.99 as medium weight, BMI score between 25.0 and 
29.99 as overweight and BMI score over 30.0 as obese 
[9]. According to NCEP ATP III Criteria, the women 
having waist circumference>88 and men having waist 
circumference >102 were evaluated as pathologic. 
Blood pressure was measured in sitting position after 
the patient had a rest for 10 minutes. According to 
NCEP ATP III Criteria, patients having blood pressure 
<130/85 mmHg were evaluated as normal and patient 
having blood pressure ≥130/85 mmHg were evaluated 
as hypertensive [4].  
Data Analysis  
Data was analyzed by SPSS (Statistical Package for 
Social Sciences) 17.0 software. Percentages and Chi-
Square test were used in statistical analysis.  
 
Results 
 
% 83.6 of the patients was 40 years old or above, % 
58.6 of the patients was woman, %81.6 of the patients 
was married and %79.9 of the patients has been 
working. %41.8 of the patients was not literate. %81.0 
of the patients did not smoke. According to BMI, % 
44.8 of the patients was fat and %26.9 of them was 
obese. % 48.1 of the patients have scored MS research 
form between 5-8 showing medium risk for MS and 
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%42.5 of the patients have scored between 9-14 
showing high risk for MS (Table 1).%67.5 of the 
patients had a chronic disease, %58.6 of the patients 
had hypertension, %41 of them had heart disease, 
%19.4 of them had diabetes, %8.6 of them had asthma, 
%4.1 of them had renal impairment and %1.1 of them 
had cancer. When the medical history of the patient’ 
families were examined, %67.9 of the patients had 
chronic disease in their families. When other diseases 
were examined, %41.0 of the patients had 
hypertension, %43.3 of them had heart disease, %35.8 
of them had diabetes and %9.7 of them had asthma in 
their families (Table 2).Age was the most important 
factor that affects MS risk. %98,2 of the patients older 
than 40 had high MS risk while %1.8 of the patients 
younger than 40 had high MS risks. According to age 
groups, the changes of MS risk was statistically 
significant (p=0.001).  Gender is another important 
factor affecting MS risk. Woman having medium or 
high MS risk are statistically more than man having 
medium or high MS risk (p=0.001).  The difference 
between patients’ educational level and metabolic 
syndrome risks was statistically significant (p=0.034). 
The difference between patients marital status and MS 
risk was statistically significant (p=0.001). The 
difference between chronic disease existence and 
metabolic syndrome risk were statistically significant 
(p=0.001). When the chronic diseases affecting 
metabolic syndrome risks were examined, it was 
identified that hearth disease, diabetes, hypertension 
and asthma affect MS risk (p<0.05). The difference 
between MS risk and chronic disease existence in 
family is statistically significant (p=0.019). The 
existence of diabetes, hypertension, asthma in family 
medical history affect MS risk (p<0.05). Smoking 
condition of the patients did not affect their MS risk 
(p>0.05). The difference between BMİ and MS risk is 
statistically significant and patient having high MS risk 
were mostly fat or obese (Table 3). Statistically 
significant difference was identified between of waist 
circumference and MS risk at woman (p=0.001). 
However, the difference between man’s waist 
circumference and MS risk was not statistically 
significant (p=0.17).  
 
Table 1: Characteristics of sociodemographic, BMİ*, MS risk 
 
Patient Characteristics n(%) Patient Characteristics n(%) 
Age 
40 ↓ 
40 and ↑ 
 
Gender 
Female 
Male 
 
Marital status 
Single 
Married 
 
Educational status 
Illiterate 
literate 
Primary school 
Middle School 
High school 
University 
 
44(16.4) 
224(83.6) 
 
 
157(58.6) 
111(41.4) 
 
 
36(13.4) 
232(81.6) 
 
 
110(41.0) 
48(17.9) 
46(17.2) 
18(6.7) 
25(9.3) 
21(7.8) 
Working status 
Yes 
No 
 
Smoking 
Yes 
No 
 
BKİ 
Under weight 
Normal weight 
Overweight 
Obesity 
 
Metabolic Syndrome Risk 
Low risk 
Medium risk 
 High risk 
 
214(79.9) 
54(20.1) 
 
 
51(19.0) 
217(81.0) 
 
 
6(2.2) 
70(26.1) 
120(44.8) 
72(26.9) 
 
 
25(9.3) 
129(48.1) 
114(42.5) 
 
 
 
* Body mass index 
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Table 2: Patients and their family’s disease history 
 
Patient disease history n(%) Family disease history n(%) 
Chronic disease 
No 
Yes  
Diabetes 
No 
Yes  
Hypertension 
No 
Yes  
Cardiac disease 
No 
Yes  
Renal disease 
No 
Yes  
Cancer 
No 
Yes  
Asthma 
No 
Yes  
 
87(32.5) 
181(67.5) 
 
216(80.6) 
52(19.4) 
 
111(41.4) 
157(58.6) 
158(59.0) 
110(41.0) 
 
257(95.9) 
11(4.1) 
 
265(98.9) 
3(1.1) 
 
245(91.4) 
23(8.6) 
Chronic disease 
No 
Yes  
Diabetes 
No 
Yes  
Hypertension 
No 
Yes  
Cardiac disease 
No 
Yes  
Renal disease 
No 
Yes  
Cancer 
No 
Yes  
Asthma 
No 
Yes  
 
86(32.1) 
182(67.9) 
 
172(64.2) 
96(35.8) 
 
158(59.0) 
110(41.0) 
 
152(56.7) 
116(43.3) 
 
260(97.0) 
8(3.0) 
 
264(98.5) 
4(1.5) 
 
242(90.3) 
26(9.7) 
 
Table 3: Patients’ MS risk according to sociodemographic characteristics, habits, chronic disease, BMİ 
 
 
Characteristics 
Metabolic Syndrome Risk  
p value 
 
Low risk 
n(%) 
Medium risk 
n(%) 
High risk 
n(%) 
Age 
40 ↓ 
40 and ↑ 
 
12(48.0) 
13(52.0) 
 
30(23.3) 
99(76.7) 
 
2(1.8) 
112 (98.2) 
 
p=0.001 
X2=40.43 
Gender 
Female 
Male 
 
12(48.0) 
13(52.0) 
 
68(52.7) 
61(47.3) 
 
77(67.5) 
37(32.5) 
 
p=0.034 
X2=6.759 
Educational status 
Illiterate- literate 
Primary school-Middle School 
High school University 
 
  8 (32.0) 
11 (44.0) 
   6 (24.0) 
 
70 (54.3) 
31 (24.0) 
28 (21.7) 
 
80 (70.2) 
22 (19.3) 
12 (10.5) 
 
p=0.003 
X2=16.395 
Marital status 
Single 
Married 
 
9(36.0) 
16(64.0) 
 
20(15.5) 
109(84.5) 
 
7(6.1) 
107(93.9) 
 
p=0.001 
X2=16.638 
Smoking 
No 
Yes 
 
19(76.0) 
6(24.0) 
 
104(80.6) 
25(19.4) 
 
94(82.5) 
20(17.5) 
 
p=0.574 
X2=0.750 
Chronic disease 
No 
Yes 
 
17(68.0) 
8 (32.0) 
 
41(31.8) 
88(68.2) 
 
29(25.4) 
85(74.6) 
 
p=0.001 
X2=16.993 
Cardiac disease 
No 
Yes 
 
17(68.0) 
8(32.0) 
 
47(36.4) 
82(63.6) 
 
46(40.4) 
43(59.6) 
 
p=0.013 
X2=8.663 
Diabetes 
No 
Yes 
 
24(96.0) 
1(4.0) 
 
112(86.8) 
17(13.2) 
 
80(70.2) 
34 (29.8) 
 
p=0.001 
X2=14.906 
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Hypertension 
No 
Yes 
 
23(92.0) 
2(8.0) 
 
82(63.6) 
47(36.4) 
 
52(45.6) 
67(54.4) 
 
p=0.001 
X2=20.728 
Asthma 
No 
Yes 
 
25(100.0) 
0(0.0) 
 
121(93.8) 
8(6.2) 
 
99(86.8) 
15(13.2) 
 
p=0.042 
X2=6.321 
Family chronic disease 
No 
Yes 
 
13(52.0) 
12(48.0) 
 
45(34.9) 
84(65.1) 
 
28(24.6) 
86(75.4) 
 
P=0.019 
X2=7.975 
History of family diabetes 
No 
Yes 
 
20(80.0) 
5(20.0) 
 
91(70.5) 
38(29.5) 
 
61(53.5) 
53(46.5) 
 
p=0.005 
X2=10.640 
History of family Hypertension 
No 
Yes 
 
18(72.0) 
7(28.0) 
 
89(54.3) 
40(45.7) 
 
51(44.7) 
63(55.3) 
 
p=0.001 
X2=16.653 
History of family cardiac disease 
No 
Yes 
 
18(72.0) 
7(28.0) 
 
70(54.3) 
59(45.7) 
 
64(56.1) 
50(43.9) 
 
p=0.258 
X2=2.710 
History of family asthma 
No 
Yes 
 
24(96.0) 
1(4.0) 
 
122(94.6) 
7(5.4) 
 
96(84.2) 
18(15.8) 
 
p=0.015 
X2=8.442 
Body Mass İndex 
Under weight 
Normal weight 
Overweight 
Obesity 
 
2(8.0) 
13(52.0) 
10(40.0) 
0(0.0) 
 
4(3.1) 
39(30.2) 
64(49.6) 
22(17.1) 
 
0(0.0) 
18(15.8) 
46(40.4) 
50(43.8) 
 
 
p=0.001 
X2=43.484 
 
Table 4: Female and male MS risk according to waist circumference 
 
Gender  Waist 
Circumference 
Low risk 
n(%) 
Medium risk 
n(%) 
High risk 
n(%) 
p value 
 
Fe
m
a
le
 
(n
=
15
7)  
<88 
>88 
 
8(17.8) 
4(3.6) 
 
27(60.0) 
41(36.6) 
 
10(22.2) 
67(59.8) 
 
p=0.001 
X2=21.7 
 
M
a
le
 
(n
=
11
1)  
<102 
>102 
 
12(13.6) 
1(4.3) 
 
50(48.4) 
11(47.8) 
 
26(29.3) 
11(47.8) 
 
p=0.17 
X2=3.4 
 
 
Discussion 
 
This study aimed to identify the MS risks and related 
factors in the patients who applied to cardiology 
outpatient clinic. It was identified that %48 of the 
patients have medium risk while %42.5 of the patients 
have high risk. Karadeniz et al., (2007) conducted a 
study to determine MS risk in medical personnel. They 
identified that %14.3 of them have high risk and %54.8 
of them have medium risk [10]. Mollaoğlu et al., 
(2010) have mentioned that %17.3 of the adults who 
applied to Family Health Center has high risk and %44 
of them has medium risks [11]. In our study, the rate of 
patients having medium and high risks is more than 
other studies. The reason for this was thought as our 
sample had patients having a cardiovascular disease or 
complaints. Most of the studies in the literature 
mentioned that age is the most effective factor in MS 
frequency [5, 7, 12-17]. In our research the patients 
having high MS risk are older than 40 years old 
(p=0.001), which is parallel to the literature. Kutlu and 
Çivi mentioned that when age increases the occurrence 
of MS increases and MS occurs frequently in people 
older than 50 [12]. Mollaoğlu et al., mentioned that 
when age increases the occurrence of MS increases and 
%87.8 of  people who have high MS risk are at 50 or 
older (p=0.001) [11].  Soysal and colleagues conducted 
a study with young adults and results that when age 
increases, MS prevalence increases [18]. The studies in 
Turkey reported that MS prevalence is between %39.6-
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49.0 in females and %28-31.2 in males [12, 14]. In our 
study, %67.5 of the people having high MS risk are 
female and gender was identified as an important factor 
that affects MS risk level (p=0.034). According to a 
study conducted in Russia reported that MS occurred in 
old female more than old males. However, they 
reported that there is no difference in MS prevalence 
between young males and females [16]. In our study, 
we have found statistically significant difference 
between educational level and MS risk (p=0.003). In 
our study, MS risk is higher in people who did not take 
formal education than the people who took formal 
education. Many study reported that education level 
affects MS prevalence and risk. These studies reported 
that MS prevalence and risk is higher in people who 
are not literate and primary school graduates [7, 11, 
12]. This finding in our study is parallel with the 
literature. The increase in industrialization and 
sedentary life style increases obesity prevalence. 
Obesity, especially visceral obesity, has role in both the 
highness of lipolytic activities and pathogenesis of MS 
because of secreted cytokines [19]. In our study, it was 
reported that %84.3 of the people having high MS risks 
are fat and obese (p=0.001). Çelik et al., reported MS 
incidence as %55.6 in people having BMI ≥30 [13]. 
Karadeniz et al., mentioned that people having high 
BMI have high MS risks [10]. Kozan et al., reported 
that abdominal obesity and high blood pressure are the 
frequent components of MS in Turkish population [14]. 
Similarly, the studies conducted in other countries 
reported that obesity is an important factor that affects 
frequency of MS [15, 17]. A study conducted in Russia 
reported that center obesity prevalence is two times 
higher in females than males [16]. An epidemiological 
study conducted with medical students in Sudan 
reported that people having MS diagnosis, are not 
obese [17]. This situation explains the highness of MS 
prevalence in females and in older people. In our 
study,%59.9 of the females having  waist 
circumference >88 cm and %47.8 of the males having 
waist circumference>102 cm have high MS risk. A 
study reported that %45.8 of the males having waist 
circumference>102 cm and %60.7 of the females 
having waist circumference>88 cm have MS 
frequencies [12]. However, waist circumference was 
identified a factor affecting MS risk in females in our 
study. In our study, we found that people having 
hypertension in themselves or in their families have 
higher MS risk (p=0.001). Kutlu and Çivi (2014) 
reported in their study that hypertension is the most 
frequent (%73) component of MS (12). Also, Soysal 
reported that blood pressure is the most frequent 
component of MS (18). Similarly a study conducted in 
China, reported hypertension as a risk factor for MS 
[20].The negative effects of smoking over 
cardiovascular diseases, cancer types and other health 
situations are known [21, 22]. Smoking causes 
decreases in HDL level and increases in LDL and 
triglyceride levels [22, 23]. In this study, it was 
revealed that smoking does not affect MS risk 
[p=0.574]. Similarly, there are studies showing that 
there is no relation between smoking and MS [24, 25]. 
For example, Kitiş et al., (2010) reported in their study 
that people who smoke have higher blood pressure, 
blood sugar and waist circumference than the people 
who do not smoke (p<0.05), but they also reported that 
there is no relation between smoking and MS 
occurrence [7]. However, a study conducted in Seoul 
reported that people having MS diagnosis have higher 
smoking prevalence [26].  
 
Conclusion  
 
Almost half of the patients who have applied to 
cardiology outpatient clinic have MS risks. Age, 
gender, marital status, smoking, chronic disease 
history, chronic disease history in family, BMI, waist 
circumference are that factors that affect MS risk. It 
was resulted that people, who are older, females, 
married, smoke, have chronic disease in themselves or 
in their family, have higher BMI and have higher waist 
circumference, have higher MS risk. It was suggested 
that non-invasive measurement devices should be 
developed to evaluate MS risks and studies should be 
conducted to determine high risk groups.  
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